Grant: Project Grant - PA: Health Economics/Health Services Research in Cancer Control
University of Toronto
$100,000.00
Accounting for equity and economic burden in priority setting for breast cancer control in India
EF 2022-23
Résumé
Cancer treatment poses an unsustainable economic burden on global health systems and on patients and families. Consequentially, there remain unacceptable inequities in access to quality and affordable cancer prevention and treatment within and between populations. Addressing these inequities is key to improving cancer outcomes and requires a concerted effort, aligned to global health systems strengthening goals.
This project examines the economic burden of breast cancer treatment and caregiving costs in India and demonstrates how to explicitly integrate equity in policy analysis for cancer control programs. A multi-methods approach will measure the costs and economic burden of breast cancer treatment from the perspectives of patients and their caregivers, including gender dimensions of caregiving and treatment decision making, at two comprehensive cancer centres in India. These data will be integrated with economic evaluation methodology to develop a policy tool to estimate the equity benefits associated with breast cancer screening and required diagnostics and therapies, alongside standard cost-effectiveness estimates for India. By examining the economic burden of breast cancer and extending the conventional cost-effectiveness approach to incorporate equity and financial protection, a stronger case can be made to governments for expanding access to necessary cancer control strategies as a health system strengthening, development, and gender equity imperative.
This project aligns with IHSPR' mandate and CIHR's vision for Global Health 3.0. By focusing on the economic burden of cancer, we stand to contribute to closing the global cancer divide and health system strengthening efforts. Further, this study will provide insights on how to embed equity and gender equity considerations in traditional economic evaluation approaches, with potential to enhance existing Canadian cancer decision-support tools.
Programme
Project Grant - PA: Health Economics/Health Services Research in Cancer Control
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
472666
Name
Essue Beverley M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Policy & Systems Management Research
Projecttitle
Accounting for equity and economic burden in priority setting for breast cancer control in India
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Health Economics/Health Services Research in Cancer Control
Keyworddelim
Breast Cancer; Caregiving Costs; Equity; Financial Toxicity; Gender Equity; Global Health; Health Economics; Health Financing; Health Systems; Priority Setting
Abstract
Cancer treatment poses an unsustainable economic burden on global health systems and on patients and families. Consequentially, there remain unacceptable inequities in access to quality and affordable cancer prevention and treatment within and between populations. Addressing these inequities is key to improving cancer outcomes and requires a concerted effort, aligned to global health systems strengthening goals.
This project examines the economic burden of breast cancer treatment and caregiving costs in India and demonstrates how to explicitly integrate equity in policy analysis for cancer control programs. A multi-methods approach will measure the costs and economic burden of breast cancer treatment from the perspectives of patients and their caregivers, including gender dimensions of caregiving and treatment decision making, at two comprehensive cancer centres in India. These data will be integrated with economic evaluation methodology to develop a policy tool to estimate the equity benefits associated with breast cancer screening and required diagnostics and therapies, alongside standard cost-effectiveness estimates for India. By examining the economic burden of breast cancer and extending the conventional cost-effectiveness approach to incorporate equity and financial protection, a stronger case can be made to governments for expanding access to necessary cancer control strategies as a health system strengthening, development, and gender equity imperative.
This project aligns with IHSPR' mandate and CIHR's vision for Global Health 3.0. By focusing on the economic burden of cancer, we stand to contribute to closing the global cancer divide and health system strengthening efforts. Further, this study will provide insights on how to embed equity and gender equity considerations in traditional economic evaluation approaches, with potential to enhance existing Canadian cancer decision-support tools.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Essue, Beverley M; Krishnamurthy, Revathy; Rodin, Danielle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~